Most Recent

image: Saving Jon

Saving Jon

By | October 1, 2016

Meet the researcher/entrepreneur who started a nonprofit that seeks to solve the science behind a rare disease that threatens the life of her younger brother.

0 Comments

image: Some Human Cancers Exhibit Low-grade Inflammation

Some Human Cancers Exhibit Low-grade Inflammation

By | October 1, 2016

NSAIDs reduce this “parainflammation,” hinting at how they help lower cancer risk.

0 Comments

image: Techniques for Assessing Genomic Copy Number Variations

Techniques for Assessing Genomic Copy Number Variations

By | October 1, 2016

As the importance of genomic copy number variations for health and disease becomes clearer, researchers are creating new ways to detect these changes in the genome.

0 Comments

image: Ocean Viruses Cataloged

Ocean Viruses Cataloged

By | September 21, 2016

An international research team triples the number of known virus types found in marine environments. 

0 Comments

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

image: Zika Update

Zika Update

By | September 7, 2016

Virus’s genome to aid in diagnoses; bees caught in crossfire of mosquito sprays; Zika spreads in Asia; US Congress revisits Zika funding

1 Comment

image: Novartis Drops Gene Therapy Research

Novartis Drops Gene Therapy Research

By | September 6, 2016

The company has shuttered its experimental cell and gene cancer therapy unit, firing more than 100 researchers.

1 Comment

image: Week in Review: August 29–September 2

Week in Review: August 29–September 2

By | September 2, 2016

Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech